Most read article(s)

Open Access
The Pharmacological Case for Cannabigerol
Rahul Nachnani, Wesley M. Raup-Konsavage and Kent E. Vrana

Journal of Pharmacology and Experimental Therapeutics February 2021, 376 (2) 204-212; DOI: https://doi.org/10.1124/jpet.120.000340
You have access
The Dual Amylin- and Calcitonin-Receptor Agonist KBP-042 Works as Adjunct to Metformin on Fasting Hyperglycemia and HbA1c in a Rat Model of Type 2 Diabetes
Sara T. Hjuler, Sofie Gydesen, Kim V. Andreassen, Morten A. Karsdal and Kim Henriksen

Journal of Pharmacology and Experimental Therapeutics July 2017, 362 (1) 24-30; DOI: https://doi.org/10.1124/jpet.117.241281
Open Access
Drug Discovery Strategies for SARS-CoV-2
Zeenat A. Shyr, Kirill Gorshkov, Catherine Z. Chen and Wei Zheng

Journal of Pharmacology and Experimental Therapeutics October 2020, 375 (1) 127-138; DOI: https://doi.org/10.1124/jpet.120.000123
Open Access
Discovery of M5049: A Novel Selective Toll-Like Receptor 7/8 Inhibitor for Treatment of Autoimmunity
Jaromir Vlach, Andrew T. Bender, Melinda Przetak, Albertina Pereira, Aditee Deshpande, Theresa L. Johnson, Sonja Reissig, Evgeni Tzvetkov, Djordje Musil, Noune Tahmassian Morse, Philipp Haselmayer, Simone C. Zimmerli, Shinji L. Okitsu, Robert L. Walsky and Brian Sherer

Journal of Pharmacology and Experimental Therapeutics March 2021, 376 (3) 397-409; DOI: https://doi.org/10.1124/jpet.120.000275
Open Access
Nose-to-Brain Delivery
Zian Wang, Guojun Xiong, Wai Chun Tsang, Andreas G. Schätzlein and Ijeoma F. Uchegbu

Journal of Pharmacology and Experimental Therapeutics September 2019, 370 (3) 593-601; DOI: https://doi.org/10.1124/jpet.119.258152
You have access
Ocular Drug Delivery: Present Innovations and Future Challenges
Vrinda Gote, Sadia Sikder, Jeff Sicotte and Dhananjay Pal

Journal of Pharmacology and Experimental Therapeutics September 2019, 370 (3) 602-624; DOI: https://doi.org/10.1124/jpet.119.256933
You have access
Targeting the Myofibroblast Genetic Switch: Inhibitors of Myocardin-Related Transcription Factor/Serum Response Factor–Regulated Gene Transcription Prevent Fibrosis in a Murine Model of Skin Injury
Andrew J. Haak, Pei-Suen Tsou, Mohammad A. Amin, Jeffrey H. Ruth, Phillip Campbell, David A. Fox, Dinesh Khanna, Scott D. Larsen and Richard R. Neubig

Journal of Pharmacology and Experimental Therapeutics June 2014, 349 (3) 480-486; DOI: https://doi.org/10.1124/jpet.114.213520
You have access
Immune Responses Alter Taste Perceptions: Immunomodulatory Drugs Shape Taste Signals during Treatments
Anthony Y. Huang

Journal of Pharmacology and Experimental Therapeutics December 2019, 371 (3) 684-691; DOI: https://doi.org/10.1124/jpet.119.261297
Open Access
Improved Inhibitory and Absorption, Distribution, Metabolism, Excretion, and Toxicology (ADMET) Properties of Blebbistatin Derivatives Indicate That Blebbistatin Scaffold Is Ideal for drug Development Targeting Myosin-2
Máté Gyimesi, Anna Á. Rauscher, Sharad Kumar Suthar, Kamirán Á. Hamow, Kinga Oravecz, István Lőrincz, Zsolt Borhegyi, Máté T. Déri, Ádám F. Kiss, Katalin Monostory, Pál Tamás Szabó, Suman Nag, Ivan Tomasic, Jacob Krans, Patrick J. Tierney, Mihály Kovács, László Kornya and András Málnási-Csizmadia

Journal of Pharmacology and Experimental Therapeutics March 2021, 376 (3) 358-373; DOI: https://doi.org/10.1124/jpet.120.000167
You have access
The Role of Smoking and Nicotine in the Transmission and Pathogenesis of COVID-19
Ali Ehsan Sifat, Saeideh Nozohouri, Heidi Villalba, Bhuvaneshwar Vaidya and Thomas J. Abbruscato

Journal of Pharmacology and Experimental Therapeutics December 2020, 375 (3) 498-509; DOI: https://doi.org/10.1124/jpet.120.000170

Main menu

User menu

Search

Most read article(s)

Pages

Navigate

More Information

ASPET's Other Journals